ERIC SCHAFER to Disease-Free Survival
This is a "connection" page, showing publications ERIC SCHAFER has written about Disease-Free Survival.
Connection Strength
0.022
-
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. J Clin Oncol. 2022 07 01; 40(19):2106-2118.
Score: 0.022